| Year |
Citation |
Score |
| 2024 |
Feole M, Pozo Devoto VM, Dragišić N, Arnaiz C, Bianchelli J, Texlová K, Kovačovicova K, Novotny JS, Havas D, Falzone TL, Stokin GB. Swedish Alzheimer's disease variant perturbs activity of retrograde molecular motors and causes widespread derangement of axonal transport pathways. The Journal of Biological Chemistry. 107137. PMID 38447793 DOI: 10.1016/j.jbc.2024.107137 |
0.793 |
|
| 2023 |
Čarna M, Novotny JS, Dragišić N, Slavik H, Sheardova K, Geda YE, Vyhnalek M, Laczo J, Hort J, Mao Z, Rissman RA, Hajduch M, Dammer EB, Stokin GB. Missorting of Plasma miRNAs in Aging and Alzheimer's Disease. Journal of Neurochemistry. PMID 36892419 DOI: 10.1111/jnc.15801 |
0.49 |
|
| 2023 |
Čarna M, Onyango IG, Katina S, Holub D, Novotny JS, Nezvedova M, Jha D, Nedelska Z, Lacovich V, Vyvere TV, Houbrechts R, Garcia-Mansfield K, Sharma R, David-Dirgo V, Vyhnalek M, ... ... Stokin GB, et al. Pathogenesis of Alzheimer's disease: Involvement of the choroid plexus. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 36825691 DOI: 10.1002/alz.12970 |
0.56 |
|
| 2022 |
Pozo Devoto VM, Lacovich V, Feole M, Bhat P, Chovan J, Čarna M, Onyango IG, Dragišić N, Sűsserová M, Barrios-Llerena ME, Stokin GB. Unraveling axonal mechanisms of traumatic brain injury. Acta Neuropathologica Communications. 10: 140. PMID 36131329 DOI: 10.1186/s40478-022-01414-8 |
0.799 |
|
| 2022 |
Pozo Devoto VM, Onyango IG, Stokin GB. Mitochondrial behavior when things go wrong in the axon. Frontiers in Cellular Neuroscience. 16: 959598. PMID 35990893 DOI: 10.3389/fncel.2022.959598 |
0.806 |
|
| 2021 |
Onyango IG, Bennett JP, Stokin GB. Mitochondrially-Targeted Therapeutic Strategies for Alzheimer's Disease. Current Alzheimer Research. PMID 34879805 DOI: 10.2174/1567205018666211208125855 |
0.304 |
|
| 2019 |
Devoto VP, Lacovich V, Carna M, Feole M, Stokin G. Cytoskeletal and molecular changes in axonal swellings Ibro Reports. 6: S119. DOI: 10.1016/J.Ibror.2019.07.379 |
0.508 |
|
| 2017 |
Pozo Devoto VM, Dimopoulos N, Alloatti M, Pardi MB, Saez TM, Otero MG, Cromberg LE, Marín-Burgin A, Scassa ME, Stokin GB, Schinder AF, Sevlever G, Falzone TL. αSynuclein control of mitochondrial homeostasis in human-derived neurons is disrupted by mutations associated with Parkinson's disease. Scientific Reports. 7: 5042. PMID 28698628 DOI: 10.1038/S41598-017-05334-9 |
0.721 |
|
| 2017 |
Lacovich V, Espindola SL, Alloatti M, Pozo Devoto V, Cromberg LE, Čarná ME, Forte G, Gallo JM, Bruno L, Stokin GB, Avale ME, Falzone TL. Tau Isoforms Imbalance Impairs the Axonal Transport of the Amyloid Precursor Protein in Human Neurons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 37: 58-69. PMID 28053030 DOI: 10.1523/JNEUROSCI.2305-16.2017 |
0.774 |
|
| 2016 |
Lacovich V, Espindola SL, Alloatti M, Pozo Devoto V, Cromberg L, Čarná M, Forte G, Gallo JM, Bruno L, Stokin GB, Avale ME, Falzone TL. Tau isoforms imbalance impairs the axonal transport of the amyloid precursor protein in human neurons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 27837099 DOI: 10.1523/JNEUROSCI.2305-16.2016 |
0.777 |
|
| 2015 |
Lacovich V, Alloatti M, Avale ME, Espindola S, Falzone T, Čarna M, Krell-Roesch J, Forte G, Geda YE, Stokin GB. P4-013: Perturbation of 3R/4R tau ratio impairs app axonal transport in neurons derived from human embryonic stem cells (HESC) Alzheimer's & Dementia. 11: P770-P770. DOI: 10.1016/J.Jalz.2015.06.1717 |
0.747 |
|
| 2013 |
Mellone M, Kestoras D, Andrews MR, Dassie E, Crowther RA, Stokin GB, Tinsley J, Horne G, Goedert M, Tolkovsky AM, Spillantini MG. Tau pathology is present in vivo and develops in vitro in sensory neurons from human P301S tau transgenic mice: a system for screening drugs against tauopathies. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 18175-89. PMID 24227726 DOI: 10.1523/Jneurosci.4933-12.2013 |
0.414 |
|
| 2012 |
Falzone TL, Stokin GB. Imaging amyloid precursor protein in vivo: an axonal transport assay. Methods in Molecular Biology (Clifton, N.J.). 846: 295-303. PMID 22367820 DOI: 10.1007/978-1-61779-536-7_25 |
0.782 |
|
| 2009 |
Shah SB, Nolan R, Davis E, Stokin GB, Niesman I, Canto I, Glabe C, Goldstein LS. Examination of potential mechanisms of amyloid-induced defects in neuronal transport. Neurobiology of Disease. 36: 11-25. PMID 19497367 DOI: 10.1016/J.Nbd.2009.05.016 |
0.719 |
|
| 2009 |
Falzone TL, Stokin GB, Lillo C, Rodrigues EM, Westerman EL, Williams DS, Goldstein LS. Axonal stress kinase activation and tau misbehavior induced by kinesin-1 transport defects. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 29: 5758-67. PMID 19420244 DOI: 10.1523/Jneurosci.0780-09.2009 |
0.806 |
|
| 2008 |
Stokin GB, Almenar-Queralt A, Gunawardena S, Rodrigues EM, Falzone T, Kim J, Lillo C, Mount SL, Roberts EA, McGowan E, Williams DS, Goldstein LS. Amyloid precursor protein-induced axonopathies are independent of amyloid-beta peptides. Human Molecular Genetics. 17: 3474-86. PMID 18694898 DOI: 10.1093/Hmg/Ddn240 |
0.798 |
|
| 2006 |
Salehi A, Delcroix JD, Belichenko PV, Zhan K, Wu C, Valletta JS, Takimoto-Kimura R, Kleschevnikov AM, Sambamurti K, Chung PP, Xia W, Villar A, Campbell WA, Kulnane LS, Nixon RA, ... ... Stokin GB, et al. Increased App expression in a mouse model of Down's syndrome disrupts NGF transport and causes cholinergic neuron degeneration. Neuron. 51: 29-42. PMID 16815330 DOI: 10.1016/J.Neuron.2006.05.022 |
0.663 |
|
| 2006 |
Stokin GB, Goldstein LS. Axonal transport and Alzheimer's disease. Annual Review of Biochemistry. 75: 607-27. PMID 16756504 DOI: 10.1146/Annurev.Biochem.75.103004.142637 |
0.727 |
|
| 2006 |
Stokin GB, Goldstein LS. Linking molecular motors to Alzheimer's disease. Journal of Physiology, Paris. 99: 193-200. PMID 16459060 DOI: 10.1016/J.Jphysparis.2005.12.085 |
0.652 |
|
| 2006 |
Carna M, Holub D, Vyhnalek M, Katina S, Nedelska Z, Hort J, Pirrotte P, Hajduch M, Stokin GB. P2-257: BIOMARKERS OF CSF: ALZHEIMER'S PROGRESSION TRACKING Alzheimer's & Dementia. 14: P774-P774. DOI: 10.1016/J.Jalz.2018.06.946 |
0.3 |
|
| 2005 |
Stokin GB, Lillo C, Falzone TL, Brusch RG, Rockenstein E, Mount SL, Raman R, Davies P, Masliah E, Williams DS, Goldstein LS. Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease. Science (New York, N.Y.). 307: 1282-8. PMID 15731448 DOI: 10.1126/Science.1105681 |
0.812 |
|
| 2005 |
Stokin GB, Queralt-Almenar A, Goldstein LS. [P-077]: Identifying early changes in the pathogenesis of Alzheimer's disease with potential diagnostic and therapetic relevance Alzheimer's & Dementia. 1: S32-S32. DOI: 10.1016/j.jalz.2005.06.151 |
0.469 |
|
| 2004 |
Stokin GB. O1-04-04 Axonal pathology in mouse models of Alzheimer's disease Neurobiology of Aging. 25: S17. DOI: 10.1016/S0197-4580(04)80055-1 |
0.405 |
|
| 2000 |
Kamal A, Stokin GB, Yang Z, Xia CH, Goldstein LS. Axonal transport of amyloid precursor protein is mediated by direct binding to the kinesin light chain subunit of kinesin-I. Neuron. 28: 449-59. PMID 11144355 DOI: 10.1016/S0896-6273(00)00124-0 |
0.757 |
|
| Show low-probability matches. |